Profile data is unavailable for this security.
About the company
SUGI HOLDINGS CO.,LTD. is a Japan-based holding company mainly engaged in management of the drug stores and dispensing business. Through its subsidiaries, the Company is engaged in the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. The Company also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services.
- Revenue in JPY (TTM)791.72bn
- Net income in JPY24.77bn
- Incorporated1982
- Employees8.72k
- LocationSugi Holdings Co Ltd62-1, Shine, Yokone-machiOBU-SHI 474-0011JapanJPN
- Phone+81 562452700
- Fax+81 562452702
- Websitehttps://www.sugi-hd.co.jp/
More ▼
Mergers & acquisitions
| Acquired company | 7649:TYO since announced | Transaction value |
|---|---|---|
| I&H Co Ltd | 3.38% | -- |
| NIHONDO Co Ltd | 19.55% | -- |
Data delayed at least 20 minutes, as of Nov 22 2024 06:30 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kusuri No Aoki Holdings Co Ltd | 449.77bn | 12.77bn | 337.47bn | 4.74k | 24.80 | 2.48 | 13.46 | 0.7503 | 129.47 | 129.47 | 4,604.24 | 1,293.64 | 1.52 | 7.11 | 32.47 | 94,988,180.00 | 4.31 | 5.39 | 6.25 | 8.16 | 26.88 | 27.89 | 2.84 | 3.37 | 0.9561 | 68.99 | 0.4633 | 6.97 | 15.31 | 11.73 | -0.1542 | 2.94 | 4.19 | 12.54 |
| Yaoko Co Ltd | 674.17bn | 18.98bn | 388.53bn | 4.35k | 20.11 | 2.12 | 11.85 | 0.5763 | 461.14 | 461.14 | 16,473.45 | 4,383.11 | 1.96 | 41.63 | 64.26 | 155,089,500.00 | 5.61 | 5.38 | 7.31 | 7.04 | 27.73 | 28.27 | 2.87 | 2.85 | 1.02 | 37.27 | 0.2956 | 22.13 | 9.76 | 7.33 | 15.11 | 9.11 | 2.90 | 12.89 |
| Tsuruha Holdings Inc | 1.04tn | 24.81bn | 397.09bn | 11.62k | 15.78 | 1.36 | 8.69 | 0.3814 | 507.91 | 507.91 | 21,313.83 | 5,888.44 | 1.91 | 5.09 | 21.65 | 89,590,700.00 | 5.04 | 5.56 | 8.08 | 9.21 | 30.42 | 29.70 | 2.64 | 2.99 | 0.7253 | 42.62 | 0.1466 | 39.67 | 5.92 | 5.60 | -4.56 | -0.5861 | 30.80 | 12.53 |
| Sundrug Co Ltd | 775.66bn | 29.34bn | 410.50bn | 6.66k | 13.71 | 1.54 | 8.99 | 0.5292 | 250.88 | 250.88 | 6,632.09 | 2,229.34 | 1.96 | 6.45 | 32.68 | 116,429,800.00 | 7.43 | 7.88 | 10.49 | 11.55 | 25.27 | 24.86 | 3.78 | 3.82 | 0.9398 | 51.61 | 0.1166 | 38.73 | 8.88 | 5.03 | 13.32 | 4.01 | 27.84 | 11.55 |
| Sugi Holdings Co Ltd | 791.72bn | 24.77bn | 474.98bn | 8.72k | 18.26 | 1.86 | 11.86 | 0.5999 | 136.90 | 136.90 | 4,375.13 | 1,346.16 | 1.93 | 6.87 | 16.42 | 90,752,180.00 | 6.03 | 6.11 | 9.76 | 9.30 | 30.91 | 30.38 | 3.13 | 3.21 | 0.8864 | -- | 0.0439 | 23.96 | 11.51 | 8.79 | 15.64 | 4.14 | 12.58 | 2.71 |
| Cosmos Pharmaceutical Corp | 985.18bn | 26.09bn | 537.61bn | 5.51k | 20.41 | 2.25 | 11.53 | 0.5457 | 329.18 | 329.18 | 12,430.53 | 2,992.83 | 2.14 | 9.47 | 1,711.86 | 178,733,100.00 | 5.67 | 6.59 | 10.42 | 12.35 | 19.88 | 19.92 | 2.65 | 3.03 | 0.3209 | 401.07 | 0.1016 | 14.02 | 16.59 | 9.57 | 2.76 | 4.97 | 13.96 | 19.14 |
Data as of Nov 22 2024. Currency figures normalised to Sugi Holdings Co Ltd's reporting currency: Japanese Yen JPY
18.43%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Orbis Investment Management Ltd.as of 31 Aug 2024 | 6.72m | 3.54% |
| Baillie Gifford & Co.as of 15 Jan 2024 | 6.66m | 3.51% |
| MFS International (UK) Ltd.as of 30 Sep 2024 | 4.72m | 2.48% |
| Nomura Asset Management Co., Ltd.as of 07 Nov 2024 | 3.87m | 2.04% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 2.97m | 1.57% |
| Boston Partners Global Investors, Inc.as of 30 Sep 2024 | 2.93m | 1.54% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.90m | 1.00% |
| Nikko Asset Management Co., Ltd.as of 08 Nov 2024 | 1.81m | 0.95% |
| Harris Associates LPas of 30 Sep 2024 | 1.74m | 0.92% |
| Daiwa Asset Management Co. Ltd.as of 31 Oct 2024 | 1.68m | 0.88% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
